AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 2 |
Visa
V
|
+$283M |
| 3 |
CVS Health
CVS
|
+$195M |
| 4 |
Texas Instruments
TXN
|
+$188M |
| 5 |
Progressive
PGR
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$274M |
| 2 |
Microsoft
MSFT
|
+$263M |
| 3 |
Comcast
CMCSA
|
+$248M |
| 4 |
Amphenol
APH
|
+$238M |
| 5 |
Elevance Health
ELV
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.59% |
| 2 | Financials | 14.66% |
| 3 | Healthcare | 14.25% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARGO
1551
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.67M | ﹤0.01% |
54,344
-572
| -1% | -$27.2K |
|
|
FDC
1552
DELISTED
First Data Corporation
FDC
| $2.67M | ﹤0.01% |
202,576
-700
| -0.3% | -$9.02K |
|
1553
Copa Holdings
CPA
$5.56B
| $2.66M | ﹤0.01% |
30,272
-326
| -1% | -$24.7K |
|
1554
Southern First Bancshares
SFST
$582M
| $2.65M | ﹤0.01% |
95,965
+100
| +0.1% | +$2.75K |
|
|
HAWK
1555
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $2.65M | ﹤0.01% |
87,716
-22,920
| -21% | -$759K |
|
|
EE
1556
DELISTED
El Paso Electric Company
EE
| $2.65M | ﹤0.01% |
56,566
-1,577
| -3% | -$73.6K |
|
|
N
1557
DELISTED
Netsuite Inc
N
| $2.64M | ﹤0.01% |
23,885
-17,049
| -42% | -$1.72M |
|
|
VVC
1558
DELISTED
Vectren Corporation
VVC
| $2.64M | ﹤0.01% |
52,642
-700
| -1% | -$35.5K |
|
1559
AGCO
AGCO
$8.78B
| $2.64M | ﹤0.01% |
53,441
-6,240
| -10% | -$300K |
|
1560
iShares MSCI Switzerland ETF
EWL
$2.12B
| $2.64M | ﹤0.01% |
86,292
-223
| -0.3% | -$6.74K |
|
1561
Puma Biotechnology
PBYI
$406M
| $2.62M | ﹤0.01% |
39,140
-7,700
| -16% | -$389K |
|
1562
Pricesmart
PSMT
$5.75B
| $2.62M | ﹤0.01% |
31,276
-4,300
| -12% | -$354K |
|
1563
Dorman Products
DORM
$4.01B
| $2.62M | ﹤0.01% |
40,930
-2,000
| -5% | -$123K |
|
1564
Globus Medical
GMED
$10.4B
| $2.61M | ﹤0.01% |
115,830
| – | – |
|
|
GIMO
1565
DELISTED
Gigamon Inc.
GIMO
| $2.61M | ﹤0.01% |
47,700
-1,000
| -2% | -$45.4K |
|
1566
Corcept Therapeutics
CORT
$10.2B
| $2.6M | ﹤0.01% |
400,240
+176,920
| +79% | +$1.03M |
|
1567
Viavi Solutions
VIAV
$9.75B
| $2.6M | ﹤0.01% |
352,032
| – | – |
|
1568
Euronet Worldwide
EEFT
$3.02B
| $2.6M | ﹤0.01% |
31,784
-10,316
| -25% | -$790K |
|
|
HK
1569
DELISTED
Halcon Resources Corporation
HK
| $2.6M | ﹤0.01% |
+277,027
| New | +$3.25M |
|
1570
American States Water
AWR
$3.39B
| $2.59M | ﹤0.01% |
64,781
-2,838
| -4% | -$117K |
|
|
ANCB
1571
DELISTED
Anchor Bancorp
ANCB
| $2.59M | ﹤0.01% |
101,692
-3,040
| -3% | -$76.9K |
|
|
GHDX
1572
DELISTED
Genomic Health, Inc.
GHDX
| $2.59M | ﹤0.01% |
89,625
+29,080
| +48% | +$810K |
|
|
PPLI
1573
People Inc
PPLI
$3.1B
| $2.58M | ﹤0.01% |
231,303
-20,423
| -8% | -$216K |
|
1574
Ribbon Communications
RBBN
$354M
| $2.58M | ﹤0.01% |
331,488
+155,190
| +88% | +$1.36M |
|
1575
Herbalife
HLF
$1.23B
| $2.58M | ﹤0.01% |
83,154
-12,000
| -13% | -$379K |
|
Similar funds
AllianceBernstein's Q3 2016 Portfolio in Review
As of Q3 2016, AllianceBernstein held 3,058 positions worth $118B, up 2% from $116B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q3 2016 filing shows 95 new, 1,049 increased, 1,331 reduced and 82 closed positions. Its largest new stake was Teva Pharmaceuticals: 2,294,681 shares worth $106M. The largest sale was Pfizer, an estimated $274M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q3 2016 buy was Teva Pharmaceuticals: 2,294,681 shares worth $106M.
- AllianceBernstein added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $567M increase.
- AllianceBernstein's biggest Q3 2016 reduction was Pfizer, cutting an estimated $274M.
- AllianceBernstein fully exited EMC CORPORATION in Q3 2016, selling an estimated $99.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $118B portfolio in Q3 2016.
- AllianceBernstein opened 95 new positions and closed 82 in Q3 2016.
- AllianceBernstein's portfolio value rose 2% quarter-over-quarter to $118B.
Based on AllianceBernstein's 13F filing for Q3 2016, filed 10 Nov 2016.